60 Degrees Pharmaceuticals, Inc. Common Stock Working Capital to Net Assets Ratio

Latest as of June 2026: 84.1%

60 Degrees Pharmaceuticals, Inc. Common Stock working capital to net assets ratio. 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a Working Capital to Net Assets ratio of 84.1% as of June 2026. Working capital of $2.13 Million (current assets of $3.73 Million minus current liabilities of $1.61 Million) is measured against net assets of $2.53 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 60 Degrees Pharmaceuticals, Inc. Common tangible net worth ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

84.1%
Working Capital / Net Assets

Working Capital

$2.13 Million
USD

Current Assets

$3.73 Million
USD

Current Liabilities

$1.61 Million
USD

Working Capital to Net Assets Ratio of 60 Degrees Pharmaceuticals, Inc. Common Stock (2020–2025)

Working capital to net assets ratio of 60 Degrees Pharmaceuticals, Inc. Common Stock from 2020 to 2025. This chart shows how 60 Degrees Pharmaceuticals, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 84.1%, reflecting working capital of $2.13 Million against net assets of $2.53 Million USD. See SXTP cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

60 Degrees Pharmaceuticals, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2020–2025)

60 Degrees Pharmaceuticals, Inc. Common Stock working capital to net assets ratio by year from 2020 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for 60 Degrees Pharmaceuticals, Inc. Common Stock from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is 60 Degrees Pharmaceuticals, Inc. Common 's balance sheet.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 90.3% $3.05 Million $3.38 Million $4.90 Million $1.84 Million ▼ -4.0 pp
2024 94.3% $3.73 Million $3.96 Million $5.39 Million $1.66 Million ▲ +2.4 pp
2023 91.9% $4.41 Million $4.80 Million $7.24 Million $2.84 Million ▼ -2.7 pp
2022 94.5% $-22.82 Million $-24.15 Million $1.10 Million $23.92 Million ▲ +97.5 pp
2021 -3.0% $541.20K $-18.15 Million $1.18 Million $635.47K ▲ +2.6 pp
2020 -5.6% $1.01 Million $-18.07 Million $2.44 Million $1.43 Million —
pp = percentage points